AMARIN PHARMA INC v. HIKMA PHARMACEUTICALS USA INC (2020)

United States Court of Appeals, Federal Circuit.

AMARIN PHARMA, INC., Amarin Pharmaceuticals Ireland Limited, Plaintiffs-Appellants v. HIKMA PHARMACEUTICALS USA INC., Hikma Pharmaceuticals International Limited, Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Defendants-Appellees

2020-1723, 2020-1901

Decided: September 03, 2020

(Dyk, Reyna, and Hughes, Circuit Judges). Jonathan Elliot Singer, Fish & Richardson, PC, San Diego, CA, argued for plaintiffs-appellants. Also represented by Oliver Richards; Deanna Jean Reichel, Minneapolis, MN; Nitika Gupta Fiorella, Wilmington, DE; Jeffrey B. Elikan, Christopher Neil Sipes, Eric Ritland Sonnenschein, Covington & Burling LLP, Washington, DC. Charles B. Klein, Winston & Strawn LLP, Washington, DC, argued for all defendants-appellees. Defendants-appellees Hikma Pharmaceuticals USA Inc., Hikma Pharmaceuticals International Limited also represented by Claire A. Fundakowski; Alison Michelle Heydorn, Chicago, IL; Eimeric Reig-Plessis, San Francisco, CA. Constance Huttner, Windels Marx Lane & Mittendorf LLP, Madison, NJ, for defendants-appellees Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. Also represented by Beth C. Finkelstein, Caroline Sun, James Barabas. Ashley Charles Parrish, King & Spalding LLP, Washington, DC, for amicus curiae Aimed Alliance. Also represented by Paul Alessio Mezzina, Jesse Snyder. Rachel J. Elsby, Akin Gump Strauss Hauer & Feld LLP, Washington, DC, for amicus curiae Biotechnology Innovation Organization. Also represented by Jason Weil, Philadelphia, PA; Melissa A. Brand, Hansjorg Sauer, Biotechnology Innovation Organization, Washington, DC.

JUDGMENT

This Cause having been heard and considered, it is Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.

Per Curiam